{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T22:50:19Z","timestamp":1783983019446,"version":"3.55.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicalnutritionjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Nutrition"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.clnu.2019.02.019","type":"journal-article","created":{"date-parts":[[2019,2,15]],"date-time":"2019-02-15T11:33:39Z","timestamp":1550230419000},"page":"455-459","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["Non-alcoholic fatty liver in hereditary fructose intolerance"],"prefix":"10.1016","volume":"39","author":[{"given":"Luis","family":"Ald\u00e1miz-Echevarr\u00eda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"de las Heras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Luz","family":"Couce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Alcalde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isidro","family":"Vitoria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Bueno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Blasco-Alonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Concepci\u00f3n Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00f3nica","family":"Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Su\u00e1rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Andrade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olatz","family":"Villate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8685","key":"10.1016\/j.clnu.2019.02.019_bib1","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/0140-6736(90)90603-3","article-title":"Molecular analysis of aldolase B genes in hereditary fructose intolerance","volume":"335","author":"Cross","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.clnu.2019.02.019_bib2","series-title":"Hereditary Fructose Intolerance, Source: GeneReviews\u00ae [Internet]","year":"1993"},{"key":"10.1016\/j.clnu.2019.02.019_bib3","doi-asserted-by":"crossref","first-page":"S273","DOI":"10.1007\/s10545-009-1219-4","article-title":"Secondary disorders of glycosylation in inborn errors of fructose metabolism","volume":"32","author":"Quintana","year":"2009","journal-title":"J\u00a0Inherit Metab Dis"},{"issue":"1","key":"10.1016\/j.clnu.2019.02.019_bib4","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.clnu.2019.02.019_bib5","doi-asserted-by":"crossref","first-page":"263","DOI":"10.4254\/wjh.v6.i5.263","article-title":"Obesity and non-alcoholic fatty liver disease: disparate associations among Asian populations","volume":"6","author":"Wong","year":"2014","journal-title":"World J Hepatol"},{"issue":"3","key":"10.1016\/j.clnu.2019.02.019_bib6","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1007\/s10620-009-1081-0","article-title":"Nonalcoholic fatty liver disease: a review and update","volume":"55","author":"Lewis","year":"2010","journal-title":"Dig Dis Sci"},{"issue":"6","key":"10.1016\/j.clnu.2019.02.019_bib7","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1053\/j.gastro.2008.02.077","article-title":"Diagnosis and therapy of nonalcoholic steatohepatitis","volume":"134","author":"Torres","year":"2008","journal-title":"Gastroenterology"},{"issue":"11","key":"10.1016\/j.clnu.2019.02.019_bib8","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/nrgastro.2013.183","article-title":"NAFLD, NASH and liver cancer","volume":"10","author":"Michelotti","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.clnu.2019.02.019_bib9","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.jhep.2017.09.021","article-title":"Hypertension, diabetes, atherosclerosis and NASH: cause or consequence?","volume":"68","author":"Lonardo","year":"2018","journal-title":"J\u00a0Hepatol"},{"issue":"3","key":"10.1016\/j.clnu.2019.02.019_bib10","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.ymgme.2015.01.001","article-title":"Aldolase-B knockout in mice phenocopies hereditary fructose intolerance in humans","volume":"114","author":"Oppelt","year":"2015","journal-title":"Mol Genet Metabol"},{"issue":"6","key":"10.1016\/j.clnu.2019.02.019_bib11","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.anpedi.2010.03.017","article-title":"Valoraci\u00f3n del peso, talla e IMC en ni\u00f1os, adolescentes y adultos j\u00f3venes de la Comunidad Aut\u00f3noma de Madrid","volume":"73","author":"L\u00f3pez de Lara","year":"2010","journal-title":"An Pediatr"},{"issue":"5","key":"10.1016\/j.clnu.2019.02.019_bib12","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1053\/gast.2002.36572","article-title":"AGA technical review on nonalcoholic fatty liver disease","volume":"123","author":"Sanyal","year":"2002","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.clnu.2019.02.019_bib13","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1093\/ndt\/gfq404","article-title":"Methylation cycle, arginine-creatine pathway and asymmetric dimethylarginine in paediatric renal transplant","volume":"26","author":"Andrade","year":"2011","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"10.1016\/j.clnu.2019.02.019_bib14","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1157\/13102513","article-title":"\u00cdndice HOMA y QUICKI, insulina y p\u00e9ptido C en ni\u00f1os sanos. Puntos de corte de riesgo cardiovascular","volume":"66","author":"Garc\u00eda Cuartero","year":"2007","journal-title":"An Pediatr"},{"issue":"2","key":"10.1016\/j.clnu.2019.02.019_bib15","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/MEG.0b013e3282f172e6","article-title":"Different genotypes in a large Italian family with recurrent hereditary fructose intolerance","volume":"20","author":"Caciotti","year":"2008","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.clnu.2019.02.019_bib16","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s10545-009-9008-7","article-title":"Increased prevalence of mutant null alleles that cause hereditary fructose intolerance in the American population","volume":"33","author":"Coffee","year":"2010","journal-title":"J\u00a0Inherit Metab Dis"},{"issue":"9","key":"10.1016\/j.clnu.2019.02.019_bib17","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/j.mayocp.2015.06.013","article-title":"Recommendations for diagnosis, referral for liver biopsy, and treatment of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis","volume":"90","author":"Spengler","year":"2015","journal-title":"Mayo Clin Proc"},{"issue":"13","key":"10.1016\/j.clnu.2019.02.019_bib18","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1016\/j.celrep.2017.03.011","article-title":"Liver-specific activation of AMPK prevents steatosis on a high-fructose diet","volume":"18","author":"Woods","year":"2017","journal-title":"Cell Rep"},{"issue":"4","key":"10.1016\/j.clnu.2019.02.019_bib19","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/nrd1344","article-title":"Erratum: AMP kinase and malonyl-CoA: targets for therapy of the metabolic syndrome","volume":"3","author":"Ruderman","year":"2004","journal-title":"Nat Rev Drug Discov"},{"issue":"6","key":"10.1016\/j.clnu.2019.02.019_bib20","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.cmet.2006.05.005","article-title":"Identification and characterization of a small molecule AMPK activator that treats key components of type 2 diabetes and the metabolic syndrome","volume":"3","author":"Cool","year":"2006","journal-title":"Cell Metabol"},{"issue":"10","key":"10.1016\/j.clnu.2019.02.019_bib21","doi-asserted-by":"crossref","first-page":"e47948","DOI":"10.1371\/journal.pone.0047948","article-title":"Uric acid stimulates fructokinase and accelerates fructose metabolism in the development of fatty liver","volume":"7","author":"Lanaspa","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.clnu.2019.02.019_bib22","first-page":"637","article-title":"The mechanism of adenine triphosphate depletion in the liver after a load of fructose. A kinetic study of liver adenylate deaminase","volume":"134","author":"Van den Berghe","year":"1977","journal-title":"Biochem J"},{"issue":"4","key":"10.1016\/j.clnu.2019.02.019_bib23","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1203\/00006450-199410000-00004","article-title":"Changes of liver metabolite concentrations in adults with disorders of fructose metabolism after intravenous fructose by 31P magnetic resonance spectroscopy","volume":"36","author":"Boesiger","year":"1994","journal-title":"Pediatr Res"},{"issue":"8565","key":"10.1016\/j.clnu.2019.02.019_bib24","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/S0140-6736(87)91419-X","article-title":"Study of hereditary fructose intolerance by use of 31P magnetic resonance spectroscopy","volume":"330","author":"Oberhaensli","year":"1987","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.clnu.2019.02.019_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1074\/jbc.M110.121806","article-title":"Metformin activates AMP kinase through inhibition of AMP deaminase","volume":"286","author":"Ouyang","year":"2011","journal-title":"J\u00a0Biol Chem"},{"issue":"6","key":"10.1016\/j.clnu.2019.02.019_bib26","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1002\/hep.23229","article-title":"The plasma lipidomic signature of nonalcoholic steatohepatitis","volume":"50","author":"Puri","year":"2009","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.clnu.2019.02.019_bib27","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1002\/hep.26499","article-title":"Finding the balance: the role of S-adenosylmethionine and phosphatidylcholine metabolism in development of nonalcoholic fatty liver disease","volume":"58","author":"Jacobs","year":"2013","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.clnu.2019.02.019_bib28","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1002\/hep.26399","article-title":"Excess S-adenosylmethionine reroutes phosphatidylethanolamine towards phosphatidylcholine and triglyceride synthesis","volume":"58","author":"Martinez-Una","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.clnu.2019.02.019_bib29","doi-asserted-by":"crossref","DOI":"10.1210\/jc.2010-2493","article-title":"Dietary methionine restriction increases fat oxidation in obese adults with metabolic syndrome","volume":"96","author":"Plaisance","year":"2011","journal-title":"J\u00a0Clin Endocrinol Metabol"},{"issue":"11","key":"10.1016\/j.clnu.2019.02.019_bib30","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1016\/j.metabol.2013.06.012","article-title":"Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice","volume":"62","author":"Malloy","year":"2013","journal-title":"Metabolism"},{"issue":"3","key":"10.1016\/j.clnu.2019.02.019_bib31","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.jhep.2014.10.019","article-title":"S-Adenosylmethionine increases circulating very-low density lipoprotein clearance in non-alcoholic fatty liver disease","volume":"62","author":"Mart\u00ednez-U\u00f1a","year":"2015","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.clnu.2019.02.019_bib32","series-title":"The online metabolic and molecular bases of inherited disease","article-title":"Disorders of fructose metabolism","author":"Steinmann","year":"2014"}],"container-title":["Clinical Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0261561419300731?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0261561419300731?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T00:54:55Z","timestamp":1759366495000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0261561419300731"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S0261561419300731"],"URL":"https:\/\/doi.org\/10.1016\/j.clnu.2019.02.019","relation":{},"ISSN":["0261-5614"],"issn-type":[{"value":"0261-5614","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Non-alcoholic fatty liver in hereditary fructose intolerance","name":"articletitle","label":"Article Title"},{"value":"Clinical Nutrition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clnu.2019.02.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.","name":"copyright","label":"Copyright"}]}}